Page last updated: 2024-10-30

mecamylamine and Encephalitis

mecamylamine has been researched along with Encephalitis in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Encephalitis: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stuckenholz, V1
Bacher, M1
Balzer-Geldsetzer, M1
Alvarez-Fischer, D1
Oertel, WH1
Dodel, RC1
Noelker, C1

Other Studies

1 other study available for mecamylamine and Encephalitis

ArticleYear
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.
    Journal of Parkinson's disease, 2013, Volume: 3, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Bridged Bicyclo Compounds; Calcium-Binding Prot

2013